Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1330)
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
5,566
Price
$101.97
Total Value
$567.57K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
15,329
Price
$101.24
Total Value
$1.55M
Shares Held After
5,566
% of Holdings
73.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
10,354
Price
$100.22
Total Value
$1.04M
Shares Held After
20,895
% of Holdings
33.1%
BillionToOne, Inc. (BLLN)
Sakakibara Shan Riku — Chief Product Officer
Shares
1,354
Price
$125.00
Total Value
$169.25K
Shares Held After
204,000
% of Holdings
0.7%
BillionToOne, Inc. (BLLN)
Sakakibara Shan Riku — Chief Product Officer
Shares
1,355
Price
$125.00
Total Value
$169.38K
Shares Held After
205,354
% of Holdings
0.7%
BillionToOne, Inc. (BLLN)
Sakakibara Shan Riku — Chief Product Officer
Shares
1,117
Price
$125.00
Total Value
$139.62K
Shares Held After
206,709
% of Holdings
0.5%
BillionToOne, Inc. (BLLN)
Sakakibara Shan Riku — Chief Product Officer
Shares
174
Price
$125.00
Total Value
$21.75K
Shares Held After
207,826
% of Holdings
0.1%
BillionToOne, Inc. (BLLN)
Sakakibara Shan Riku — Chief Product Officer
Shares
4,000
Price
$125.00
Total Value
$500.00K
Shares Held After
208,000
% of Holdings
1.9%
NEUROCRINE BIOSCIENCES INC (NBIX)
Lippoldt Darin — Chief Legal Officer
Shares
10,000
Price
$179.60
Total Value
$1.80M
Shares Held After
54,729
% of Holdings
15.4%
Twist Bioscience Corp (TWST)
Laponis Adam — Chief Financial Officer
Shares
2,399
Price
$94.33
Total Value
$226.31K
Shares Held After
110,276
% of Holdings
2.1%
COMPUGEN LTD (CGEN)
Levine Zurit — SVP, Business Development
Shares
1,875
Price
$2.50
Total Value
$4.69K
Shares Held After
29,375
% of Holdings
6.0%
Privia Health Group, Inc. (PRVA)
Mountcastle David — EVP & Chief Financial Officer
Shares
21,275
Price
$27.67
Total Value
$588.68K
Shares Held After
164,853
% of Holdings
11.4%
Amylyx Pharmaceuticals, Inc. (AMLX)
Mazzariello Gina — Chief Legal Officer
Shares
15,000
Price
$18.32
Total Value
$274.75K
Shares Held After
194,090
% of Holdings
7.2%
Bluejay Diagnostics, Inc. (BJDX)
HRT FINANCIAL LP — 10% Owner
Shares
64,047
Price
$1.51
Total Value
$96.71K
Shares Held After
126,993
% of Holdings
50.4%
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
HRT FINANCIAL LP — 10% Owner
Shares
8,266
Price
$3.38
Total Value
$27.94K
Shares Held After
60,540
% of Holdings
13.7%
ADIAL PHARMACEUTICALS, INC. (ADIL)
Coastlands Capital LP — 10% Owner
Shares
10,053
Price
$2.79
Total Value
$28.05K
Shares Held After
383,375
% of Holdings
2.6%
ProQR Therapeutics N.V. (PRQR)
de Boer Daniel Anton — Director
Shares
150,000
Price
$1.74
Total Value
$261.00K
Shares Held After
300,000
% of Holdings
50.0%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
2,171
Price
$30.30
Total Value
$65.78K
Shares Held After
57,733
% of Holdings
3.6%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
25,000
Price
$1.96
Total Value
$48.90K
Shares Held After
461,904
% of Holdings
5.4%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,000
Price
$0.90
Total Value
$900.00
Shares Held After
368,485
% of Holdings
0.3%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
25
Price
$16.00
Total Value
$400.00
Shares Held After
135,202
% of Holdings
0.0%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
536
Price
$29.00
Total Value
$15.54K
Shares Held After
181,641
% of Holdings
0.3%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
2,111
Price
$123.81
Total Value
$261.36K
Shares Held After
63,493
% of Holdings
3.2%
INSMED Inc (INSM)
Lewis William — Director
Shares
3,359
Price
$118.52
Total Value
$398.11K
Shares Held After
259,058
% of Holdings
1.3%
INSMED Inc (INSM)
Lewis William — Director
Shares
2,335
Price
$117.62
Total Value
$274.64K
Shares Held After
262,417
% of Holdings
0.9%
INSMED Inc (INSM)
Lewis William — Director
Shares
5,005
Price
$116.55
Total Value
$583.33K
Shares Held After
264,752
% of Holdings
1.9%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
10,000
Price
$40.00
Total Value
$400.00K
Shares Held After
119,763
% of Holdings
7.7%
VIVOS INC (RDGL)
Weeks Brad Allan — President
Shares
48,000
Price
$0.08
Total Value
$3.84K
Shares Held After
987,235
% of Holdings
4.9%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
443
Price
$91.00
Total Value
$40.31K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
2,289
Price
$91.00
Total Value
$208.30K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
66
Price
$91.00
Total Value
$6.01K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
2,792
Price
$91.00
Total Value
$254.07K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
13,935
Price
$90.17
Total Value
$1.26M
Shares Held After
443
% of Holdings
96.9%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
72,036
Price
$90.17
Total Value
$6.50M
Shares Held After
2,289
% of Holdings
96.9%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
2,090
Price
$90.17
Total Value
$188.46K
Shares Held After
66
% of Holdings
96.9%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
87,848
Price
$90.17
Total Value
$7.92M
Shares Held After
2,792
% of Holdings
96.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$555.76
Total Value
$66.69K
Shares Held After
40,513
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$554.23
Total Value
$354.70K
Shares Held After
40,633
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
801
Price
$553.29
Total Value
$443.19K
Shares Held After
41,273
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,648
Price
$552.38
Total Value
$910.32K
Shares Held After
42,074
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,863
Price
$551.03
Total Value
$1.58M
Shares Held After
43,722
% of Holdings
6.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,452
Price
$550.12
Total Value
$798.78K
Shares Held After
46,585
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,536
Price
$549.01
Total Value
$843.27K
Shares Held After
48,037
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$548.16
Total Value
$241.19K
Shares Held After
49,573
% of Holdings
0.9%
Personalis, Inc. (PSNL)
Hall Christopher M — Director
Shares
100,000
Price
$15.08
Total Value
$1.51M
Shares Held After
235,986
% of Holdings
29.8%
ABEONA THERAPEUTICS INC. (ABEO)
Vasanthavada Madhav — Chief Commercial Officer
Shares
12,606
Price
$6.96
Total Value
$87.78K
Shares Held After
290,623
% of Holdings
4.2%
ABEONA THERAPEUTICS INC. (ABEO)
Seshadri Vishwas — Director
Shares
67,971
Price
$6.96
Total Value
$473.33K
Shares Held After
1,306,108
% of Holdings
4.9%
ABEONA THERAPEUTICS INC. (ABEO)
O'Malley Brendan M. — SVP, Chief Legal Officer
Shares
12,050
Price
$6.96
Total Value
$83.91K
Shares Held After
427,953
% of Holdings
2.7%
ABEONA THERAPEUTICS INC. (ABEO)
Vazzano Joseph Walter — Chief Financial Officer
Shares
24,880
Price
$6.96
Total Value
$173.26K
Shares Held After
493,557
% of Holdings
4.8%
NEUROCRINE BIOSCIENCES INC (NBIX)
Delaet Ingrid — Chief Regulatory Officer
Shares
8,433
Price
$178.72
Total Value
$1.51M
Shares Held After
16,225
% of Holdings
34.2%
Showing 1151–1200 of 1330 transactions (page 24 of 27)